RIVAS MARIO (Chief Executive Officer) received a stock award from TRANSPHORM, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/17/2021ACC: 0001209191-21-070240
DirectorOfficer· Chief Executive Officer
Since Feb 2020
+70K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
70K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+28K
Price / share
—
Trade value
—
% of position
26.5%
12/15/2021
105.62K→133.62K
Total
Net shares
+28K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/15/2021 | A · Award | +28K | — | — | 26.5% | 105.62K | 133.62K |
| Total | +28K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
42K shares
Shares
+42K
Strike price
7.99
Held after
42K
Exercisable
—
12/15/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock42K shares | 12/15/2021 | A · Award | +42K | 7.99 | — | 42K |